The amplitude and duration of the signals conveyed by the cyclic nucleotide second messengers, camp and cGMP, are controlled by their relative rates of synthesis and degradation. For many years now our laboratory has worked to understand the regulation of cyclic nucleotide degradation by phosphodiesterases (PDEs). Each animal species produce many different PDEs. To date 11 different PDE gene families have been identified most of which contain multiple genes each of which produce several different isozymes by the processes of alternative splicing of mRNA. We and others have made good progress in determining the physiological functions for some of these variant isozymes. It is the hypothesis of this proposal that many more PDE mRNA/isozyme variants remain to be identified and that until we do so, we cannot really understand the details of cyclic nucleotide mediated regulation of physiological processes. We propose an approach involving, bioinformatic searches, gene array identification, and standard methods of molecular biology and enzymology to identify, verify, clone, express, and characterize these new PDEs. We also propose to continue to determine functions for individual PDEs by characterizing the phenotypes of animals (and cells derived from these animals) that have specific disruptions of the genes encoding a particular PDE isozyme. As part of this second approach we propose to utilize a new methodology that is expected to allow conditional, reversible, tissue specific ablation of individual PDE expression. The methods make use of specific antisense and siRNA expression under the graded control of drug inducible promoters.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK021723-28
Application #
6900964
Study Section
Biochemistry Study Section (BIO)
Program Officer
Blondel, Olivier
Project Start
1978-09-15
Project End
2008-07-31
Budget Start
2005-08-01
Budget End
2006-07-31
Support Year
28
Fiscal Year
2005
Total Cost
$451,039
Indirect Cost
Name
University of Washington
Department
Pharmacology
Type
Schools of Medicine
DUNS #
605799469
City
Seattle
State
WA
Country
United States
Zip Code
98195
Temkitthawon, Prapapan; Hinds, Thomas R; Beavo, Joseph A et al. (2011) Kaempferia parviflora, a plant used in traditional medicine to enhance sexual performance contains large amounts of low affinity PDE5 inhibitors. J Ethnopharmacol 137:1437-41
Percival, Justin M; Adamo, Candace M; Beavo, Joseph A et al. (2011) Evaluation of the therapeutic utility of phosphodiesterase 5A inhibition in the mdx mouse model of duchenne muscular dystrophy. Handb Exp Pharmacol :323-44
Surapisitchat, James; Beavo, Joseph A (2011) Regulation of endothelial barrier function by cyclic nucleotides: the role of phosphodiesterases. Handb Exp Pharmacol :193-210
Hertz, Angie L; Bender, Andrew T; Smith, Kimberly C et al. (2009) Elevated cyclic AMP and PDE4 inhibition induce chemokine expression in human monocyte-derived macrophages. Proc Natl Acad Sci U S A 106:21978-83
Martinez, Sergio E; Heikaus, Clemens C; Klevit, Rachel E et al. (2008) The structure of the GAF A domain from phosphodiesterase 6C reveals determinants of cGMP binding, a conserved binding surface, and a large cGMP-dependent conformational change. J Biol Chem 283:25913-9
Poppe, Heiko; Rybalkin, Sergei D; Rehmann, Holger et al. (2008) Cyclic nucleotide analogs as probes of signaling pathways. Nat Methods 5:277-8
Askari, Bardia; Kanter, Jenny E; Sherrid, Ashley M et al. (2007) Rosiglitazone inhibits acyl-CoA synthetase activity and fatty acid partitioning to diacylglycerol and triacylglycerol via a peroxisome proliferator-activated receptor-gamma-independent mechanism in human arterial smooth muscle cells and macrophages. Diabetes 56:1143-52
Surapisitchat, James; Jeon, Kye-Im; Yan, Chen et al. (2007) Differential regulation of endothelial cell permeability by cGMP via phosphodiesterases 2 and 3. Circ Res 101:811-8
Conti, Marco; Beavo, Joseph (2007) Biochemistry and physiology of cyclic nucleotide phosphodiesterases: essential components in cyclic nucleotide signaling. Annu Rev Biochem 76:481-511
Laxman, Sunil; Riechers, Aaron; Sadilek, Martin et al. (2006) Hydrolysis products of cAMP analogs cause transformation of Trypanosoma brucei from slender to stumpy-like forms. Proc Natl Acad Sci U S A 103:19194-9

Showing the most recent 10 out of 76 publications